ÀºÇòÅâÂÊ

ÀºÇòÅâÂÊ Services FAQ Contact Us 0
Home Biotechnology Cell Therapy Market Size, Top Share, Global Trends, Forecast to 2033
Cell Therapy Market

Cell Therapy Market Size, Share & Trends Analysis Report By Product (Media, Sera, and Reagents, Cell Engineering products, Cell Culture Vessels, Cell therapy Equipment, System and Software, Other Products), By Cell Type (T-Cells, Stem Cells, Other Cells), By Cell Process (Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control), By End User (Biopharmaceutical and Biotechnology companies, CRO’s and CMO’s, Research Institutes & Cell Banks) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRBI55592DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Cell Therapy Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    6. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media, Sera, and Reagents
          1. By Value
        3. Cell Engineering products
          1. By Value
        4. Cell Culture Vessels
          1. By Value
        5. Cell therapy Equipment
          1. By Value
          2. Cell Processing Equipment
            1. Cell Processing Equipment By Value
          3. Single-use equipment
            1. Single-use equipment By Value
          4. Other Equipment
            1. Other Equipment By Value
        6. System and Software
          1. By Value
        7. Other Products
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. T-Cells
          1. By Value
        3. Stem Cells
          1. By Value
        4. Other Cells
          1. By Value
      3. By Cell Process
        1. Introduction
          1. Cell Process By Value
        2. Cell Processing
          1. By Value
        3. Cell Preservation, Distribution, and Handling
          1. By Value
        4. Process Monitoring and Quality Control
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Biopharmaceutical and Biotechnology companies
          1. By Value
        3. CRO’s and CMO’s
          1. By Value
        4. Research Institutes & Cell Banks
          1. By Value
    7. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    6. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media, Sera, and Reagents
          1. By Value
        3. Cell Engineering products
          1. By Value
        4. Cell Culture Vessels
          1. By Value
        5. Cell therapy Equipment
          1. By Value
          2. Cell Processing Equipment
            1. Cell Processing Equipment By Value
          3. Single-use equipment
            1. Single-use equipment By Value
          4. Other Equipment
            1. Other Equipment By Value
        6. System and Software
          1. By Value
        7. Other Products
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. T-Cells
          1. By Value
        3. Stem Cells
          1. By Value
        4. Other Cells
          1. By Value
      3. By Cell Process
        1. Introduction
          1. Cell Process By Value
        2. Cell Processing
          1. By Value
        3. Cell Preservation, Distribution, and Handling
          1. By Value
        4. Process Monitoring and Quality Control
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Biopharmaceutical and Biotechnology companies
          1. By Value
        3. CRO’s and CMO’s
          1. By Value
        4. Research Institutes & Cell Banks
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    6. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media, Sera, and Reagents
          1. By Value
        3. Cell Engineering products
          1. By Value
        4. Cell Culture Vessels
          1. By Value
        5. Cell therapy Equipment
          1. By Value
          2. Cell Processing Equipment
            1. Cell Processing Equipment By Value
          3. Single-use equipment
            1. Single-use equipment By Value
          4. Other Equipment
            1. Other Equipment By Value
        6. System and Software
          1. By Value
        7. Other Products
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. T-Cells
          1. By Value
        3. Stem Cells
          1. By Value
        4. Other Cells
          1. By Value
      3. By Cell Process
        1. Introduction
          1. Cell Process By Value
        2. Cell Processing
          1. By Value
        3. Cell Preservation, Distribution, and Handling
          1. By Value
        4. Process Monitoring and Quality Control
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Biopharmaceutical and Biotechnology companies
          1. By Value
        3. CRO’s and CMO’s
          1. By Value
        4. Research Institutes & Cell Banks
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Singapore
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    6. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media, Sera, and Reagents
          1. By Value
        3. Cell Engineering products
          1. By Value
        4. Cell Culture Vessels
          1. By Value
        5. Cell therapy Equipment
          1. By Value
          2. Cell Processing Equipment
            1. Cell Processing Equipment By Value
          3. Single-use equipment
            1. Single-use equipment By Value
          4. Other Equipment
            1. Other Equipment By Value
        6. System and Software
          1. By Value
        7. Other Products
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. T-Cells
          1. By Value
        3. Stem Cells
          1. By Value
        4. Other Cells
          1. By Value
      3. By Cell Process
        1. Introduction
          1. Cell Process By Value
        2. Cell Processing
          1. By Value
        3. Cell Preservation, Distribution, and Handling
          1. By Value
        4. Process Monitoring and Quality Control
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Biopharmaceutical and Biotechnology companies
          1. By Value
        3. CRO’s and CMO’s
          1. By Value
        4. Research Institutes & Cell Banks
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. The rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media, Sera, and Reagents
        1. By Value
      3. Cell Engineering products
        1. By Value
      4. Cell Culture Vessels
        1. By Value
      5. Cell therapy Equipment
        1. By Value
        2. Cell Processing Equipment
          1. Cell Processing Equipment By Value
        3. Single-use equipment
          1. Single-use equipment By Value
        4. Other Equipment
          1. Other Equipment By Value
      6. System and Software
        1. By Value
      7. Other Products
        1. By Value
    3. By Cell Type
      1. Introduction
        1. Cell Type By Value
      2. T-Cells
        1. By Value
      3. Stem Cells
        1. By Value
      4. Other Cells
        1. By Value
    4. By Cell Process
      1. Introduction
        1. Cell Process By Value
      2. Cell Processing
        1. By Value
      3. Cell Preservation, Distribution, and Handling
        1. By Value
      4. Process Monitoring and Quality Control
        1. By Value
    5. By End User
      1. Introduction
        1. End User By Value
      2. Biopharmaceutical and Biotechnology companies
        1. By Value
      3. CRO’s and CMO’s
        1. By Value
      4. Research Institutes & Cell Banks
        1. By Value
    6. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media, Sera, and Reagents
          1. By Value
        3. Cell Engineering products
          1. By Value
        4. Cell Culture Vessels
          1. By Value
        5. Cell therapy Equipment
          1. By Value
          2. Cell Processing Equipment
            1. Cell Processing Equipment By Value
          3. Single-use equipment
            1. Single-use equipment By Value
          4. Other Equipment
            1. Other Equipment By Value
        6. System and Software
          1. By Value
        7. Other Products
          1. By Value
      2. By Cell Type
        1. Introduction
          1. Cell Type By Value
        2. T-Cells
          1. By Value
        3. Stem Cells
          1. By Value
        4. Other Cells
          1. By Value
      3. By Cell Process
        1. Introduction
          1. Cell Process By Value
        2. Cell Processing
          1. By Value
        3. Cell Preservation, Distribution, and Handling
          1. By Value
        4. Process Monitoring and Quality Control
          1. By Value
      4. By End User
        1. Introduction
          1. End User By Value
        2. Biopharmaceutical and Biotechnology companies
          1. By Value
        3. CRO’s and CMO’s
          1. By Value
        4. Research Institutes & Cell Banks
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Cell Therapy Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Gilead Sciences
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Novartis
    3. Vericel Corporation
    4. Smith Nephew
    5. Kite Pharma, Inc.
    6. Osiris Therapeutics
    7. Celgene Corporation
    8. Medipost Co., Ltd.
    9. Adaptimmune Therapeutics plc.
    10. NuVasive, Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Market Overview The global acellular therapy market size was valued at USD 10.26 billion in 2023. It is estimated to reach USD 39.66 billion by 2032, growing at a CAGR of 16.21% during the forecast period (2024–2032). The increasing incidence
Buy Now
Global Report
Cell and Gene Therapy Market Size The global cell and gene therapy market size was valued at USD 30.27 billion in 2024 and is projected to reach from USD 37.14 billion in 2025 to USD 190.82 billion by 2033, expanding at a&nb
Buy Now
Global Report
Chemotherapy Market Size The global chemotherapy market size was valued at USD 10.61 billion in 2024 and is projected to reach from USD 11.52 billion in 2025 to USD 20.2 billion by 2033, growing at a CAGR of 7
Buy Now
Global Report
Cryotherapy Market Size  The global cryotherapy market size was valued at USD 201.10 million in 2024 and is expected to grow from USD 215.52 million in 2025 to USD 375.03 million by 2033, growing at a CAGR of 7.17% during th
Buy Now
Global Report
The plasma therapy market size was valued at USD 205.15 million in 2019 and is expected to grow with a CAGR of 14.8%. Factors such as rising prevalence of immunodeficiency disorder and new technology launches by important players, significanly d
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

ÀºÇòÅâÂÊ
© Copyright . All rights Reserved.